OBIO icon

Orchestra BioMed
OBIO

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$15.67
271% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Barclays
Barclays
Matt Miksic
67% 1-yr OBIO win rate
9 Jan ‘26 8 days ago
TD Cowen
TD Cowen
Joshua Jennings
100% 1-yr OBIO win rate
10 Dec ‘25 1 month ago
Chardan Capital
Chardan Capital
Keay Nakae
33% 1-yr OBIO win rate
13 Nov ‘25 2 months ago